The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...
A Phase 3 trial found Eli Lilly's oral drug orforglipron outperformed oral semaglutide for weight loss and blood sugar ...
A MAJOR high street pharmacy has launched sales of the Wegovy pill today. Superdrug has just gone live online with the ...
Morning Overview on MSN
A once-daily pill beat Ozempic’s tablet on weight and blood sugar in a major trial
A daily tablet is emerging as one of the most credible challengers yet to the injectable weight-loss drugs that reshaped the ...
Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide ...
Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like semaglutide (the ...
A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...
Dr. Reddy’s delays semaglutide supplies over quality issues, causing shares to drop amid ongoing investigations and ...
Hyderabad-based Dr. Reddy’s Laboratories on Wednesday launched its oral semaglutide biosimilar, branded Obeda, in India at a starting price of ₹99 per tablet, marking the company’s expansion in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results